Stock 8279 SYNGEN BIOTECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Syngen Biotech Co.,Ltd.

Equities

8279

TW0008279001

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
154 TWD +1.32% Intraday chart for Syngen Biotech Co.,Ltd. +2.67% +1.32%
03-06 Syngen Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Syngen Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 3,184 2,927 3,062 4,390 4,119 4,174 -
Enterprise Value (EV) 1 3,184 2,927 3,062 4,390 4,119 4,174 4,174
P/E ratio 15 x 13.6 x 12.9 x 13.7 x 15 x 13.6 x 12.9 x
Yield - - - - - - -
Capitalization / Revenue 2.45 x - 2.08 x 2.27 x 2.24 x 2.17 x 2.06 x
EV / Revenue 2.45 x - 2.08 x 2.27 x 2.24 x 2.17 x 2.06 x
EV / EBITDA - - 8.39 x - 10.2 x 8.68 x 8.4 x
EV / FCF - - - -14,310,750 x - - -
FCF Yield - - - -0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 27,101 27,101 27,101 27,101 27,101 27,101 -
Reference price 2 117.5 108.0 113.0 162.0 152.0 154.0 154.0
Announcement Date 25/03/20 09/03/21 09/03/22 20/03/23 06/03/24 - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1,297 - 1,471 1,931 1,837 1,927 2,024
EBITDA 1 - - 365 - 402.3 481 497
EBIT 1 242.9 - 281.5 362.4 302.9 340 355
Operating Margin 18.72% - 19.13% 18.77% 16.49% 17.64% 17.54%
Earnings before Tax (EBT) 1 240.3 - 295.5 396.4 333.8 383 403
Net income 1 188.8 215.6 237.8 321.2 274.8 307 324
Net margin 14.55% - 16.16% 16.64% 14.96% 15.93% 16.01%
EPS 2 7.850 7.940 8.760 11.85 10.13 11.33 11.97
Free Cash Flow - - - -306.8 - - -
FCF margin - - - -15.89% - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 25/03/20 09/03/21 09/03/22 20/03/23 06/03/24 - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 432.3 378.7 494.9 444.1 460.1 - 461.6 467.6 484 526 480 457
EBITDA - - - - - - - - - - - -
EBIT 1 77.36 70.45 110 84.83 72.83 - 71.38 71.42 92 97 66 85
Operating Margin 17.89% 18.6% 22.22% 19.1% 15.83% - 15.46% 15.27% 19.01% 18.44% 13.75% 18.6%
Earnings before Tax (EBT) 1 81.86 80.14 121.7 89.55 87.76 - 71.74 71.13 109 108 74 92
Net income 1 66.51 65.33 95.78 72.92 74.75 70.16 57.01 59.75 86 88 59 75
Net margin 15.38% 17.25% 19.35% 16.42% 16.24% - 12.35% 12.78% 17.77% 16.73% 12.29% 16.41%
EPS 2 2.450 2.410 3.530 2.690 2.760 2.590 2.100 2.200 3.180 3.240 2.180 2.770
Dividend per Share - - - - - - - - - - - -
Announcement Date 09/03/22 27/04/22 27/07/22 12/05/23 07/08/23 30/10/23 06/03/24 13/05/24 - - - -
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - -307 - - -
ROE (net income / shareholders' equity) - - 14% 17.1% - 13.1% 12.6%
ROA (Net income/ Total Assets) - - 10.5% 11.7% - 8.59% 8.37%
Assets 1 - - 2,271 2,743 - 3,574 3,871
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - 61.7 584 - 151 224
Capex / Sales - - 4.19% 30.26% - 7.84% 11.07%
Announcement Date 25/03/20 09/03/21 09/03/22 20/03/23 06/03/24 - -
1TWD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
154 TWD
Average target price
170 TWD
Spread / Average Target
+10.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SYNGEN BIOTECH CO.,LTD. Stock Syngen Biotech Co.,Ltd.
+1.32% 128M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 8279 Stock
  4. Financials Syngen Biotech Co.,Ltd.